Alteration in tumor suppressor gene TP53 plays key role early in development of bone

[News]

The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project found mutations in the tumor suppressor gene TP53 in 90 percent of osteosarcomas, suggesting the alteration plays a key role early in development of the bone cancer.

More... (http://www.news-medical.net/news/20140404/Alteration-in-tumor-suppressor-gene-TP53-plays-key-role-early-in-development-of-bone-cancer.aspx)